Suspension of trading
Valuation Exscientia plc
Stocks
EXAI
US30223G1022
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 19/11/2024 GMT
|
5-day change | 1st Jan Change | ||
| 4.840 USD | +3.20% |
|
-.--% | - |
| 20/11/24 | Exscientia plc(NasdaqGS:EXAI) dropped from S&P Global BMI Index | CI |
| 20/11/24 | Recursion Pharmaceuticals, Exscientia Complete Business Combination | MT |
Company Valuation: Exscientia plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Market Cap 1 | 1,757 | 543.6 | 628.7 |
| Change | - | -69.06% | 15.67% |
| Enterprise Value (EV) 1 | 1,200 | 51.65 | 284.6 |
| Change | - | -95.69% | 451% |
| P/E | -14.8x | -4.55x | -4.28x |
| PBR | 3.11x | 1.14x | 1.78x |
| PEG | -0x | 3.03x | -0.2x |
| Capitalization / Revenue | 64.2x | 20x | 31.3x |
| EV / Revenue | 43.9x | 1.9x | 14.2x |
| EV / EBITDA | -23.4x | -0.32x | -1.75x |
| EV / EBIT | -22x | -0.31x | -1.63x |
| EV / FCF | - | - | - |
| FCF Yield | - | - | - |
| Dividend per Share 2 | - | - | - |
| Rate of return | - | - | - |
| EPS 2 | -0.9871 | -0.9722 | -1.175 |
| Distribution rate | - | - | - |
| Net sales 1 | 27.36 | 27.22 | 20.08 |
| EBITDA 1 | -51.31 | -159.9 | -162.5 |
| EBIT 1 | -54.64 | -167.6 | -174.5 |
| Net income 1 | -49.23 | -118.7 | -146 |
| Net Debt 1 | -557 | -491.9 | -344.1 |
| Reference price 2 | 14.593 | 4.424 | 5.032 |
| Nbr of stocks (in thousands) | 120,388 | 122,878 | 124,940 |
| Announcement Date | 23/03/22 | 23/03/23 | 21/03/24 |
1GBP in Million2GBP
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 633M | ||
| 34.4x | 6.13x | 18.24x | 0.93% | 51.22B | ||
| -21.71x | 301.09x | -22.35x | -.--% | 45.38B | ||
| 48.36x | 5.61x | 30.68x | -.--% | 41.97B | ||
| 32.97x | 3.21x | 13.87x | -.--% | 42.15B | ||
| 29.48x | 8.52x | 21.54x | 0.39% | 31.95B | ||
| 34.84x | 5.71x | 25.97x | -.--% | 17.1B | ||
| 24.28x | 2.11x | 9.12x | 1.11% | 14.76B | ||
| 77.97x | 4.1x | 15.89x | -.--% | 13.91B | ||
| Average | 32.57x | 42.06x | 14.12x | 0.3% | 28.79B | |
| Weighted average by Cap. | 27.77x | 57.29x | 12.69x | 0.3% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- EXAI Stock
- Valuation Exscientia plc
Select your edition
All financial news and data tailored to specific country editions
















